Scientific publications

Verhoeff JJ on pubmed



Causes of severe visual impairment and blindness in children in the Republic of Suriname.

Heijthuijsen AA, Beunders VA, Jiawan D, de Mesquita-Voigt AM, Pawiroredjo J, Mourits M, Tanck M, Joost J.C. Verhoeff, Saeed P.



Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.

Borovski T, Beke P, van Tellingen O, Rodermond HM, Joost J.C. Verhoeff, Lascano V, Daalhuisen JB, Medema JP, Sprick MR.



Model-based, semiquantitative and time intensity curve shape analysis of dynamic contrast-enhanced MRI: A comparison in patients undergoing antiangiogenic treatment for recurrent glioma.

Lavini C,  Joost J.C. Verhoeff, Majoie CB, Stalpers LJ, Richel DJ, Maas M.


Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Svendsen A,  Joost J.C. Verhoeff Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PO, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PO, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M



Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population.

Lavini C, Joost J.C. Verhoeff


Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma.

Joost J.C. Verhoeff, Lavini C, van Linde ME, Stalpers LJ, Majoie CB, Reijneveld JC, van Furth WR, Richel DJ.


Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity.

Sottoriva A, Joost J.C. Verhoeff, Borovski T, McWeeney SK, Naumov L, Medema JP, Sloot PM, Vermeulen L.



Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.

Joost J.C. Verhoeff, van Tellingen O, Claes A, Stalpers LJ, van Linde ME, Richel DJ, Leenders WP, van Furth WR.


Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.

Joost J.C. Verhoeff, Stalpers LJ, Claes A, Hovinga KE, Musters GD, Peter Vandertop W, Richel DJ, Leenders WP, van Furth WR.


Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

Joost J.C. Verhoeff, Stalpers LJ, Van Noorden CJ, Troost D, Ramkema MD, van Bree C, Song JY, Donker M, Chekenya M, Vandertop WP, Richel DJ, van Furth WR.


Tumor microvasculature supports proliferation and expansion of glioma-propagating cells.

Borovski T, Joost J.C. Verhoeff, Ten Cate R, Cameron K, de Vries NA, van Tellingen O, Richel DJ, van Furth WR, Medema JP, Sprick MR.



Bowel perforation after radiotherapy in a patient receiving sorafenib.

Peters NA, Richel DJ, Joost J.C. Verhoeff, Stalpers LJ.



Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.

Joost J.C. Verhoeff, Stalpers LJ, Coumou AW, Koedooder K, Lavini C, Van Noorden CJ, Haveman J, Vandertop WP, van Furth WR.

Negligible radiation protection of endothelial cells by vascular endothelial growth factor.

Donker M, Van Furth WR, Mulder-Van Der Kracht S, Hovinga KE, Joost J.C. Verhoeff, Stalpers LJ, van Bree C.



Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines–a clue to radioresistance-

Hovinga KE, Stalpers LJ, van Bree C, Donker M, Joost J.C. Verhoeff, Rodermond HM, Bosch DA, van Furth WR.